1. Home
  2. IMUX vs STIM Comparison

IMUX vs STIM Comparison

Compare IMUX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • STIM
  • Stock Information
  • Founded
  • IMUX 2016
  • STIM 2003
  • Country
  • IMUX United States
  • STIM United States
  • Employees
  • IMUX N/A
  • STIM N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • STIM Medical/Dental Instruments
  • Sector
  • IMUX Health Care
  • STIM Health Care
  • Exchange
  • IMUX Nasdaq
  • STIM Nasdaq
  • Market Cap
  • IMUX 86.3M
  • STIM 192.0M
  • IPO Year
  • IMUX N/A
  • STIM 2018
  • Fundamental
  • Price
  • IMUX $1.00
  • STIM $4.36
  • Analyst Decision
  • IMUX Strong Buy
  • STIM Buy
  • Analyst Count
  • IMUX 6
  • STIM 4
  • Target Price
  • IMUX $12.67
  • STIM $4.67
  • AVG Volume (30 Days)
  • IMUX 923.9K
  • STIM 1.7M
  • Earning Date
  • IMUX 02-24-2025
  • STIM 03-04-2025
  • Dividend Yield
  • IMUX N/A
  • STIM N/A
  • EPS Growth
  • IMUX N/A
  • STIM N/A
  • EPS
  • IMUX N/A
  • STIM N/A
  • Revenue
  • IMUX N/A
  • STIM $72,711,000.00
  • Revenue This Year
  • IMUX N/A
  • STIM $3.23
  • Revenue Next Year
  • IMUX N/A
  • STIM $29.55
  • P/E Ratio
  • IMUX N/A
  • STIM N/A
  • Revenue Growth
  • IMUX N/A
  • STIM 5.03
  • 52 Week Low
  • IMUX $0.92
  • STIM $0.52
  • 52 Week High
  • IMUX $2.11
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 50.39
  • STIM 73.44
  • Support Level
  • IMUX $0.92
  • STIM $2.80
  • Resistance Level
  • IMUX $0.97
  • STIM $3.65
  • Average True Range (ATR)
  • IMUX 0.06
  • STIM 0.47
  • MACD
  • IMUX 0.01
  • STIM 0.06
  • Stochastic Oscillator
  • IMUX 66.61
  • STIM 89.01

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: